Notice of Pre-Application Information Webinar and Frequently Asked Questions (FAQs) for HEAL Initiatives RFA-DA-19-035 (UG3/UH3) and RFA-DA-19-034 (U24): Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16-30) Initiative "

Notice Number: NOT-DA-19-017

Key Dates
Release Date: January 7, 2019

Related Announcements

RFA-DA-19-035 (UG3/UH3)

RFA-DA-19-034 (U24)

Issued by
National Institute on Drug Abuse (NIDA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Mental Health (NIMH)
National Center for Complementary and Integrative Health (NCCIH)
National Institute of Child Health and Human Development (NICHD)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers.

Purpose

On December 10, 2018, the NIH issued the following Funding Opportunity Announcements (FOAs):


HEAL Initiative: Coordinating Center to Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16 30) Initiative (U24 Clinical Trial Not Allowed)

https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-034.html

HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16 30) (UG3/UH3 Clinical Trial Required)

https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-035.html

To assist potential applicants to the above-referenced FOAs, this Notice provides the following information:

  • A Pre-Application Information Webinar for potential applicants to the HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 16 30) will be provided on January 17, 2019.

HEAL Prevention Webinar Information
Date: January 17, 2019
Time: 12:30 - 2:00 pm EST

Event address for attendees (to register and attend): https://nih.webex.com/nih/onstage/g.php?MTID=e377439f43efc0136f1c75ecb8938b880


The intent of the pre-application webinar is to provide an overview of the HEAL Prevention FOAs and to address questions from potential applicants. Attendees are encouraged to register for the webinar in advance. The webinar is optional and not required for application submission. The webinar may conclude before the scheduled time depending on the number of questions.

Following the webinar, NIDA will post the slides presented during the Webinar. Prospective applicants with inquiries concerning the FOA who are unable to participate in the Webinar are encouraged to view the summary of questions and answers after the Webinar.

FAQs
FAQs will be posted on the NIDA website with a summary of questions and answers from the webinar and may be updated with additional questions and answers without further notice.

Inquiries

Please direct all inquiries to:

Jacqueline Lloyd, Ph.D
National Institute on Drug Abuse (NIDA)
Email: [email protected]